Segments - Dialyzers Market by Type (High-flux Dialyzers and Low-flux Dialyzers), Material (Synthetic and Cellulose), Usage Type (Disposable and Reusable), End-user (Hospitals, Clinics, Dialysis Centers, and Home Care Settings), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global dialyzers market size was nearly USD 3.6 Billion in 2022 and is likely to reach USD 5.5 Billion by 2031, expanding at a CAGR of 5.2% during 2023–2031. The market growth is attributed to the increasing instances of chronic renal diseases and the technological advancements in the field of medicine.
Growing trend of unhealthy lifestyles is fueling health problems, including hypertension, diabetes, and cancer, which are major factors causing the high prevalence of end-stage renal diseases. Along with it, the rapidly increasing cases of chronic renal diseases are resulting in the higher acceptance of dialysis treatments. This has propelled the demand for apparatus & equipment that are involved in the dialysis process, and therefore, is expected to boost the dialyzer market.
The dialysis machine uses a special filter to purify the blood. This filter is also commonly known as the dialyzer, or the artificial kidney. In this process, the doctor does a minor surgery, usually in the arm, to make access to the blood vessels. The blood enters from one end of the filter and goes through several thin and hollow fibers. Meanwhile, the dialysis solution passes in the opposite direction on the fibers outside. With the use of a special semipermeable membrane, the waste products from the blood are moved into the dialysis solution.
The market report finds that the COVID-19 pandemic fueled the growth of the global dialyzer market. The COVID-19 virus mostly affected those people having low immune systems. However, people suffering from several health conditions such as cancer, blood pressure, hypertension, and diabetes were highly affected by this virus. As a result, they needed frequent dialysis, which increased the demand for dialyzers in the market, as it is the key component involved in the filtration of blood during dialysis.
Rising prevalence of kidney disorders such as end-stage renal diseases (ESRD) and chronic kidney failure is projected to drive the market. A sedentary lifestyle and unhealthy eating habits are the primary factors for kidney and liver problems. Chronic kidney problems are becoming increasingly rampant and require medical care & dialysis. Moreover, disproportionate consumption of alcoholic beverages increases the risk of kidney failure, which propels the demand for dialysis treatments.
As per the National Institute of Health, around 786,000 people in the US are suffering from end-stage kidney disease (EKSD). Out of these people, approximately 71% require dialysis treatments, while 29% people require kidney transplants. Moreover, the ratio of men to women suffering from ESRD is 3:2.
Health risks and complications associated with the dialysis procedure are expected to impede the global dialyzers market during the forecast period. Complications such as cardiac arrhythmias, air embolism, bleeding, and seizures limit market growth, as patients are hesitant to opt for hemodialysis in renal disease. Furthermore, the high cost of dialysis sessions and the requirement for several such sessions, make the dialysis procedure unaffordable for several patients coming from low-to mid-income households. These factors hamper the demand for dialyzers for dialysis machines, thus, restraining the growth of the market.
Rising prevalence of diabetes, obesity, and hypertension disorders are anticipated to create lucrative growth opportunities in the market. These problems are the leading cause of chronic renal diseases, which induce dialysis treatment requirements.
As a result, there is an increasing need for undergoing dialysis treatments that require frequent replacement of equipment involved in the dialysis including catheters, dialyzers, and blood tubes to ensure proper blood purification and maintenance of the patient’s health.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Dialyzers Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Type (High-flux Dialyzers and Low-flux Dialyzers), Material (Synthetic and Cellulose), Usage Type (Disposable and Reusable), and End-user (Hospitals, Clinics, Dialysis Centers, and Home Care Settings) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
NIPRO; Nikkiso Co., Ltd; Fresenius SE & Co. KGaA; Diaverum Deutschland Gmbh.; DaVita Inc.; BD; Baxter; B. Braun SE; Asahi Kasei Corporation; and AngioDynamics |
Based on type, the global dialyzers market is bifurcated into high-flux dialyzers and low-flux dialyzers. The high-flux dialyzers segment is projected to hold a large share of the market during the projection period, owing to their high efficiency in removing the toxin molecules (especially the large ones) from the body during hemodialysis.
Therefore, patients and doctors shifting preferences from low-flux dialyzers to high-flux dialyzers for dialysis treatment. Furthermore, high-flux dialyzers show a high degree of compatibility with the upcoming technologies in hemodialysis, including online hemodialysis and hemodiafiltration.
On the basis of material, the global market is categorized into synthetic and cellulose. The synthetic segment is expected to expand at a high CAGR during the forecast period, due to the higher biocompatibility of synthetic membranes than cellulosic membranes.
The synthetic membranes are highly pervious to proteins and peptides that lie in the mid-molecular range. Furthermore, synthetic materials are strong, durable, and cost-effective compared to cellulose and absorb less water without shrinking. These factors are projected to increase the synthetic membrane dialyzers' demand.
In terms of usage type, the dialyzers market is segmented into disposable and reusable. The disposable segment is anticipated to register a robust growth rate in the coming years, owing to its safety and cost-effectiveness.
The use of disposable dialyzers reduces the risk of getting infected by denatured blood particles and the chance of errors and setbacks. Furthermore, it cuts down the cost by eliminating the expenses of maintaining sterilized rooms & equipment, training the technicians, and other recurring expenses.
Based on end-user, the market is divided into hospitals, clinics, dialysis centers, and home care settings. The dialysis centers segment is expected to generate a major revenue share of the market, as it is the primary choice of patients for getting dialysis treatments.
The dialysis centers have dedicated staff that is trained and experienced, which provides better service and ensures the proper delivery of dialysis along with quality care. Moreover, dialysis centers closely monitor the kidney’s functionality, which further reduces other medical risks and provides ideal reimbursement policies.
The home care settings segment is anticipated to expand at a significant pace in the coming years, due to the availability of cutting-edge equipment for home setups and the convenience of performing dialysis from the comfort of home.
The key benefits of home-based dialysis setups include reduced food restrictions, better flexibility for scheduling, and the ability to have frequent treatments without any disruption.
The COVID-19 pandemic increased risks for patients with existing health issues. As a result, the preference for home-based dialysis setups increased to avoid any unnecessary exposure to the infection.
In terms of region, the global dialyzers market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is anticipated to dominate the market during the projection period, owing to the increasing prevalence of hypertension and diabetics conditions. The growing acceptance of modern lifestyles has led to a rise in sedentary activities, which is further contributing to the growth of unhealthy practices.
Moreover, the increasing population of chronic renal diseases and kidney failure in emerging economies such as India and China is expected to boost the demand for dialysis treatment, which further fuels the market in the region.
The market in North America is projected to grow at a significant growth rate during the forecast period, owing to the surge in cases of chronic renal diseases. Several other factors including the growing adoption of advanced healthcare solutions and health information exchange (HIE) systems with modern equipment, increasing per capita income, and the presence of various key market players in the region are likely to contribute to the regional market growth.
The dialyzers market has been segmented on the basis of
Key players competing in the global dialyzers market are NIPRO; Nikkiso Co., Ltd; Fresenius SE & Co. KGaA; Diaverum Deutschland Gmbh.; DaVita Inc.; BD; Baxter; B. Braun SE; Asahi Kasei Corporation; and AngioDynamics.
These companies adopt several development strategies including collaboration, acquisitions, partnerships, product launches, mergers, and production expansion to cater to customers worldwide. Some of these market players are engaging in research & development activities, searching for innovative solutions to enhance patient care, and make equipment that is highly durable and not prone to errors. For instance,
On March 29, 2022, NIPRO launched SURDIAL DX Hemodialysis System in the US. The system has been designed to provide an optimal dialysis treatment experience for clinicians and patients.
In May 2021, Davita Inc. partnered with Baxter International to develop its home renal care program using Baxter’s HomeChoice Claria, an automated peritoneal dialysis (APD) equipment. It is a significant step in promoting home dialysis for patients and is anticipated to propel the company’s growth in home dialysis program.